Table 3.
Patient characteristics
| ID | Age | Sex | Ethnicity | HLA class I | HBeAg |
|---|---|---|---|---|---|
| C1 | 57 | F | Black African | A2A24 B44B58 C3C16 | Neg |
| C2 | 46 | F | Asian | A24A31 B35B51 C1C14 | Neg |
| C3 | 43 | M | Arab | A2A3 B44B47 C6C16 | Neg |
| C4 | 35 | M | Asian | A11A33 B44B55 C3C7 | Neg |
| C5 | 52 | M | Asian | A2A33B40B51 C14C15 | Pos |
| C6 | 33 | M | White European | A2 B14B18 C7C8 | Neg |
| C7 | 49 | F | Asian | A1A11 B35B52 C4C7 | Neg |
| C8 | 39 | F | White European | A3A74B15B35 C4 | Neg |
| C9 | 29 | F | White European | A1A32 B40B44 C3C16 | Neg |
| C10 | 65 | M | White European | A2A29 B7B44 C7C16 | Pos |
| C11 | 30 | F | White European | A2 B38B51 C12C15 | Neg |
| C12 | 26 | F | White European | A2A24 B18B38 C7C12 | Neg |
| C13 | 43 | F | Asian | A2A26 B56B59 C1C7 | Neg |
| C14 | 46 | M | White European | A1A2 B37B51 C6C15 | Neg |
| C15 | 73 | M | White European | A2A3 B7 C7 | Neg |
| C16 | 53 | M | Asian | A11A24 B13B18 C3C7 | Neg |
| C17 | 29 | F | White European | A2 B13 C6 | Neg |
| C18 | 61 | F | Asian | A11A33 B13B58 C3 | Neg |
| C19 | 40 | F | Asian | A11A33 B44B59 C1C14 | Neg |
| C20 | 51 | F | Black African | A29A30 B18B45 C6C7 | Pos |
| C21 | 34 | F | Asian | A24A26 B13B40 C3C6 | Pos |
| C22 | 30 | M | White European | A2A26 B38B51 C12C15 | Neg |
| C23 | 62 | F | White European | A2A68 B15B44 C3C7 | Neg |
| C24 | 51 | M | White European | A2A3 B7B18 C7 | Neg |
| C25 | 61 | M | White European | A2A26 B7B51 C1C12 | Neg |
| C26 | 34 | F | Asian | A24A26 B13B40 C3C6 | Pos |
| C27 | 61 | F | White European | N/A | Neg |
| C28 | 49 | M | Asian | N/A | Neg |
| C29 | 37 | M | Asian | N/A | Pos |
| C30 | 23 | M | White European | N/A | Neg |
| R31 | 40 | F | White European | A2 B15B44 C1C5 | |
| R32 | 30 | F | White European | A2A68 B35B44 C4C5 | |
| R33 | N/A | N/A | White European | A2A26 B38B40 C12C15 | |
| R34 | 48 | M | White European | A23A26 B35B44 C4 | |
| R35 | 65 | F | White European | A1A2 B7B8 C7 | |
| R36 | 43 | F | White European | A1A11 B8B15 C7 | |
| R37 | 38 | M | White European | A2A11 B15B55 C3 | |
| R38 | 69 | F | White European | A2 B7B8 C7 | |
| R39 | 73 | F | White European | N/A | |
| R40 | 25 | F | White European | N/A |
Normal ALT levels were found in all patients except patient C18 and C19 where ALT levels were elevated to 59 and 66 IU/mL (normal range for females is 10–45 IU/mL). No patients were double positive or double negative for HBeAg/anti-HBeAg. Median HBV DNA in the HBeAg positive patients were 81,000 IU/mL (2 – 400.000 IU/mL) and 0.019 IU (0 – 5500 IU/mL) in the HBV negative patients, no statistics were made on HBV genotype since quantification was not possible in 12 of the 30 patients. N/A: not available; F: female; M: male; Pos: positive; Neg: negative